A Study to Investigate Atezolizumab Subcutaneous in Patients With Previously Treated Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Clinical trial NCT03735121 · COMPLETED
Trial details
- NCT number
- NCT03735121
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-12-27
- Primary completion
- 2022-04-26
- Enrollment
- 438
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.